首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   21154篇
  免费   1991篇
  国内免费   1263篇
耳鼻咽喉   225篇
儿科学   282篇
妇产科学   245篇
基础医学   2325篇
口腔科学   405篇
临床医学   2658篇
内科学   3036篇
皮肤病学   231篇
神经病学   1019篇
特种医学   734篇
外国民族医学   3篇
外科学   2336篇
综合类   3674篇
现状与发展   5篇
一般理论   6篇
预防医学   1607篇
眼科学   506篇
药学   2027篇
  28篇
中国医学   1414篇
肿瘤学   1642篇
  2024年   98篇
  2023年   356篇
  2022年   914篇
  2021年   1091篇
  2020年   822篇
  2019年   649篇
  2018年   716篇
  2017年   617篇
  2016年   585篇
  2015年   870篇
  2014年   982篇
  2013年   1053篇
  2012年   1507篇
  2011年   1597篇
  2010年   1129篇
  2009年   987篇
  2008年   1258篇
  2007年   1218篇
  2006年   1182篇
  2005年   1023篇
  2004年   796篇
  2003年   780篇
  2002年   685篇
  2001年   523篇
  2000年   539篇
  1999年   444篇
  1998年   276篇
  1997年   222篇
  1996年   175篇
  1995年   194篇
  1994年   149篇
  1993年   80篇
  1992年   133篇
  1991年   112篇
  1990年   84篇
  1989年   75篇
  1988年   76篇
  1987年   70篇
  1986年   54篇
  1985年   44篇
  1984年   37篇
  1983年   24篇
  1982年   18篇
  1981年   15篇
  1980年   18篇
  1979年   31篇
  1977年   16篇
  1973年   11篇
  1972年   10篇
  1971年   9篇
排序方式: 共有10000条查询结果,搜索用时 9 毫秒
81.
目的:研究大肠癌Lovo细胞上皮钙粘附素(E-Cadherin),神经钙粘附素(N-Cadherin)的表达及常用化学治疗药物对其表达的影响。方法:应用逆转录聚合酶链反应(RT-PCR)法检测大肠癌Lovo细胞E-Cad-herin,N-Cadherin的表达,并通过几种不同的化疗药物(顺铂、吡柔比星、丝裂霉素、5-FU)不同浓度和时间作用后,对E-Cadherin,N-Cadherin表达的影响。结果:不同化疗药物对大肠癌Lovo细胞N=Cadherin表达无影响,高浓度顺铂和高浓度吡柔比星二组出现-Cadherin表达,其它各组未见表达。结论:大肠癌常用的化疗药物无论低浓度持续用药,还是高浓度短时间用药,对大肠癌Lovo细胞N-Cadherin的表达无抑制作用,说明上述药物不能通过抑制N—Cadherin的表达,而起到抗癌作用。高浓度顺铂和吡柔比星二组显示E-Cadherin的表达,表现出抑癌的作用,从而提示在大肠癌化疗时,顺铂和吡柔比星更适合于高浓度短时间应用。  相似文献   
82.
目的 通过对24例阴道肿瘤患者的B超声像图分析,总结B超诊断阴道肿瘤的方法。方法 收集24例1995~2002年,我院门诊及住院患者的病史资料及声像图,结合病理结果分析声像图特征,并与病理加以对照。结果 24例患者声像图表现为囊性、实质性、囊实性肿瘤。结论 通过对声像图的分析,探讨了B超诊断阴道肿瘤的可行性、声像图特征及该方法的局限性。  相似文献   
83.
对127例IgA肾病(IgAN)患者和25例非IgA系膜增殖性肾炎血清进行了抗内皮细胞抗体AECA的检测。结果表明:IgA肾病患者和非IgA系膜增殖性肾炎患者血清AECA-IgG较正常对照组高,而IgAN患者较非IgA系膜增殖性肾炎患者AECA-IgG的水平高,P〈0.05。IgAN患者的AECA-IgA水平较正常对照组高。IgAN患者按AECA水平分为阳性与阴性组,对两组硬化面积比进行比较,未见  相似文献   
84.
Previous studies on human cortical area 39 suggested that neuron:glial ratios differed between the sexes. These findings were the inspiration for the present investigation which dealt with neuronal and glial counts in area 39 in the male and female rat cerebral cortex. Transverse, celloidin or frozen sections, were cut from male and female brains (respectively) from 90-day-old Long-Evans rats. Neurons and glia were counted on enlarged photographs of stained sections, including area 39, with 35-mm Kodak Panatomic-X film using a Zeiss photomicroscope (X400). Five-by-three-inch prints were taped together in sequence to yield a 640X enlarged "montage" of area 39. Five cell types were differentiated with reference to a standard: neurons, astrocytes, oligodendrocytes, "dark astrocytes," and unidentified glia. The data were analyzed with a two-way analysis of variance (ANOVA: five cell types by two hemispheres). Student's t test and a paired t test were used when appropriate. The neuron:glial ratios in the male rats were consistently higher than those in the females in both hemispheres. The male right side had 12% (P less than 0.05) more neurons than the left; the female had 13% (P less than 0.05) more neurons on the left than the right. Similar, but not identical, asymmetrical patterns were seen with the glial cells.  相似文献   
85.
偏头痛是临床常见的慢性致残性的神经系统疾病,超过半数的患者会因为偏头痛的发作而影响正常生活。近年来,大量研究表明偏头痛与卵圆孔未闭之间存在着一定的联系,但因为卵圆孔未闭发病率较高且引发偏头痛发作的病理机制不明,两者之间的因果关系尚存争议,经皮卵圆孔封堵术是否为治疗卵圆孔未闭合并偏头痛的有效治疗手段亦成为研究热点。该文将围绕卵圆孔未闭与偏头痛的相关性、两者间可能存在的发病机制以及封堵术治疗偏头痛的疗效展开综述。  相似文献   
86.
87.
Hemolytic uremic syndrome (HUS) is an uncommon but potentially life-threatening complication of hematopoietic stem cell transplantation. We retrospectively studied the medical records of 293 children who underwent allogeneic bone marrow transplantation at St. Jude Children's Research Hospital between 1992 and 1999 to describe the clinical course of and to identify risk factors for transplant-associated HUS. Conditioning regimens included cyclophosphamide, cytarabine, and total body irradiation for patients with hematologic malignancies (n = 244); patients with nonmalignant diseases (n = 49) received disease-specific regimens. Grafts from unrelated or mismatched related donors were depleted of T lymphocytes, whereas matched sibling grafts were unmanipulated. All patients received cyclosporine as prophylaxis for graft-versus-host disease. Recipients of grafts from matched siblings also received pentoxifylline or short-course methotrexate. HUS developed in 28 (9.6%) patients at a median of 171 days after transplantation. We identified older donor age (P = .029), use of antithymocyte globulin in the conditioning regimen (P = .008), and recipient CMV seronegativity (P = .011) as being associated with an increased risk of HUS. With a multiple regression analysis, the use of antithymocyte globulin (beta = .86; P = .04) and recipient cytomegalovirus seronegativity (beta = .93; P = .035) remained significant risk factors for the development of HUS.  相似文献   
88.
89.
Human ORFeome Version 1.1: A Platform for Reverse Proteomics   总被引:6,自引:0,他引:6       下载免费PDF全文
The advent of systems biology necessitates the cloning of nearly entire sets of protein-encoding open reading frames (ORFs), or ORFeomes, to allow functional studies of the corresponding proteomes. Here, we describe the generation of a first version of the human ORFeome using a newly improved Gateway recombinational cloning approach. Using the Mammalian Gene Collection (MGC) resource as a starting point, we report the successful cloning of 8076 human ORFs, representing at least 7263 human genes, as mini-pools of PCR-amplified products. These were assembled into the human ORFeome version 1.1 (hORFeome v1.1) collection. After assessing the overall quality of this version, we describe the use of hORFeome v1.1 for heterologous protein expression in two different expression systems at proteome scale. The hORFeome v1.1 represents a central resource for the cloning of large sets of human ORFs in various settings for functional proteomics of many types, and will serve as the foundation for subsequent improved versions of the human ORFeome.  相似文献   
90.
A multi-channel hearing prosthesis for profound-to-total hearing loss   总被引:1,自引:0,他引:1  
A multi-channel cochlear implant hearing prosthesis providing 22 separate channels of stimulation has been developed. The electronics for the implantable receiver-stimulator have been incorporated on a single chip, using digital circuits and employing CMOS technology. The chip is enclosed in a titanium capsule with platinum/ceramic electrode feed-throughs. A pocket-sized speech processor and directional microphone extract the following speech parameters: signal amplitude, fundamental frequency and formant frequency. The fundamental frequency is coded as electric pulse rate, and formant frequency by electrode position. The speech processor has been realized using hybrid circuits and CMOS gate arrays. The multi-channel prosthesis has undergone a clinical trial on four postlingually deaf patients with profound-total hearing losses. The speech perception results indicate that they were able to obtain open-set speech recognition scores for phonetically balanced words, CID sentences and spondees. In all cases the tests showed significant improvements when using the cochlear prosthesis combined with lipreading compared to lipreading alone.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号